Literature DB >> 6092935

Amphotropic retrovirus vector system for human cell gene transfer.

J Sorge, D Wright, V D Erdman, A E Cutting.   

Abstract

Retroviral vectors have been constructed for gene transfer in mammalian and avian cells, however most retroviral vector systems are complicated by the spread of a replication-competent helper virus. This problem has been circumvented by segregating the viral genome into cis- and trans-acting components. By establishing helper cell lines that produce the trans-acting viral gene products, one can propagate the cis-acting component in them and harvest defective viral particles that contain only the cis-acting component. The cis-acting component can provide a useful vehicle for the highly efficient transfer of genes into target cells. The defective vector systems described to date, however, are restricted in host range to murine, avian, rat, and dog cells. We describe a helper-free vector system based entirely on an amphotropic murine virus with a wide mammalian host range, including the ability to carry out efficient gene transfer into human cells. We also describe a double mutation constructed in the trans-acting genome which reduces the frequency of replication-competent recombinant viruses to undetectable levels.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092935      PMCID: PMC368980          DOI: 10.1128/mcb.4.9.1730-1737.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  28 in total

1.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

2.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

3.  An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: biological and biochemical characterization.

Authors:  M Linial; E Medeiros; W S Hayward
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

4.  Expression of genes introduced into cells by retroviral infection is more efficient than that of genes introduced into cells by DNA transfection.

Authors:  L H Hwang; E Gilboa
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

5.  Retrovirus transfer of a bacterial gene into mouse haematopoietic progenitor cells.

Authors:  A Joyner; G Keller; R A Phillips; A Bernstein
Journal:  Nature       Date:  1983 Oct 6-12       Impact factor: 49.962

6.  The terminal nucleotides of retrovirus DNA are required for integration but not virus production.

Authors:  A T Panganiban; H M Temin
Journal:  Nature       Date:  1983 Nov 10-16       Impact factor: 49.962

7.  Evidence for intrachromosomal gene conversion in cultured mouse cells.

Authors:  R M Liskay; J L Stachelek
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

8.  Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5' long terminal repeat and the start of the gag gene.

Authors:  S Watanabe; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

9.  Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors.

Authors:  S Watanabe; H M Temin
Journal:  Mol Cell Biol       Date:  1983-12       Impact factor: 4.272

10.  A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): gene transfer into cells obtained from humans deficient in HPRT.

Authors:  A D Miller; D J Jolly; T Friedmann; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

View more
  51 in total

1.  A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses.

Authors:  P Roux; P Jeanteur; M Piechaczyk
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  Alignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design.

Authors:  E A Golemis; N A Speck; N Hopkins
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

3.  Regulation of cytomegalovirus late-gene expression: differential use of three start sites in the transcriptional activation of ICP36 gene expression.

Authors:  F S Leach; E S Mocarski
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

4.  Generation of a helper cell line for packaging avian leukosis virus-based vectors.

Authors:  P Savatier; C Bagnis; P Thoraval; D Poncet; M Belakebi; F Mallet; C Legras; F L Cosset; J L Thomas; Y Chebloune
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

5.  In vitro synthesis of infectious retroviral RNA.

Authors:  F Flamant; J A Sorge
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

6.  Overcoming interference to retroviral superinfection results in amplified expression and transmission of cloned genes.

Authors:  R K Bestwick; S L Kozak; D Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

7.  An embryonic DNA-binding protein specific for the promoter of the retrovirus long terminal repeat.

Authors:  F Flamant; C C Gurin; J A Sorge
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

8.  Mus cervicolor murine leukemia virus isolate M813 belongs to a unique receptor interference group.

Authors:  V Prassolov; S Hein; M Ziegler; D Ivanov; C Münk; J Löhler; C Stocking
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

9.  Mechanisms of inhibition of nuclear hormone receptor-dependent hepatitis B virus replication by hepatocyte nuclear factor 3beta.

Authors:  Hong Tang; Alan McLachlan
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Development of a retroviral vector for inducible expression of transforming growth factor beta 1.

Authors:  M L McGeady; P M Arthur; M Seidman
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.